Hjem › Juvenil arthritis › Texas
Juvenil arthritis kliniske forsøg i Texas
4 studier for Juvenil arthritis søger deltagere på steder i Texas.
Officiel studietekst (engelsk)
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
- Texas Arthritis Center, El Paso
RekruttererFase 1
Alder 2 til 17 · Alle køn · Opdateret 28. sep. 2026 · NCT06751238A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cook Childrens Medical Center, Fort Worth
RekruttererFase 3
Alder 3 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06663332A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Child Neurology Consultants of Austin /ID# 260562, Austin
RekruttererFase 3
Alder 5 til 17 · Alle køn · Opdateret 1. sep. 2026 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- University of Texas Southwestern Medical Center Dallas, Dallas
- Baylor College of Medicine Pediatric Immunology Allergy Rheumatology, Houston
RekruttererObservationsstudie
Op til 21 år · Alle køn · Opdateret 27. aug. 2026 · NCT02418442Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.